Wontech Co.
Wontech Co. is a South Korean medical device manufacturer (KOSDAQ: 336570) that vertically integrates laser and energy-based systems — including the Oligio RF, Picocare picosecond, Lavieen thulium, and Holinwon holmium product lines — for dermatologists, plastic surgeons, MedSpas, and surgical hospitals across 80+ countries.
- Company typePublic
- Founded1999
- HeadquartersDaejeon, South Korea
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wontech Co. does
Wontech Co., Ltd. is a South Korea-based medical device manufacturer (KOSDAQ: 336570, founded 1999, headquartered in Daejeon) specializing in laser and energy-based systems for aesthetic and surgical applications. The company independently designs and manufactures both the laser source and the power supply system in-house — a vertical integration uncommon in the industry — producing a portfolio that includes monopolar RF devices (Oligio, Oligio X, Oligio Kiss, Tightan), picosecond and Q-switched lasers (Picocare Majesty, PicoAlex, PicoAndy, Pastelle Pro), thulium lasers (Lavieen), dual-wavelength hybrid systems (Sandro Dual), vascular lasers (V-Laser, VeinCare), and holmium surgical lasers (HOLINWON PRIMA and PRO). In 2026 it extended into biometric monitoring (PETRA & LIME) and AI-assisted pain therapy (ELLISE) at CES, and began development of consumer-grade OligioHome devices for the home beauty market.
Wontech sells primarily to dermatologists, plastic surgeons, aesthetic MedSpas, and urology/surgical hospital departments, using a hybrid direct-and-distributor model through four wholly-owned regional subsidiaries (USA, Japan, China, Thailand/Asia) and channel partners in 80+ countries. Revenue is generated through one-time capital equipment sales (Oligio X US MSRP $85,000) supplemented by a growing recurring consumables/tips stream (KRW 74 billion in Q1 2026) tied to the installed base. Consolidated 2025 revenue reached KRW 1,568 billion (~$1.1 billion) with a 33% operating margin and a 77.5% export ratio; Q1 2026 revenue of KRW 402 billion grew 7.6% YoY with gross margin expanding to 71.1%.
The company is co-led by CEOs Kim Jong-won and Kim Jung-hyun and is positioning for a strategic shift from a technology-driven manufacturer to a global consumer-facing brand, funded in part by a KRW 75 billion convertible bond from PACM Private Equity (May 2026) and supported by an executive bench drawn from Samsung Electronics, HP, Cutera, and Jeisys Medical. Recent milestones include MSCI Global Small Cap Index inclusion (2023), a US FDA-approved Holinwon Prima (Asia's first FDA-cleared holmium surgical laser), and three consecutive years of #1 consumer preference ranking in Korea for the Oligio brand.
Wontech Co. firmographics
Firmographics- Name
- Wontech Co.
- Legal name
- 원텍 주식회사 (Wontech Co., Ltd.)
- Website
- https://wtlaser.com
- Company type
- Public
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Wontech Co. is a South Korean medical device manufacturer (KOSDAQ: 336570) that vertically integrates laser and energy-based systems — including the Oligio RF, Picocare picosecond, Lavieen thulium, and Holinwon holmium product lines — for dermatologists, plastic surgeons, MedSpas, and surgical hospitals across 80+ countries.
- Ownership category
- akta.pro rank
Wontech Co. industry classification
Industry- Product category
- Medical Aesthetic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Laser & Energy-Based Dermatology (HLAKACAF)
- akta.pro secondary industries
- Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)
Keywords
Where Wontech Co. is headquartered
LocationHeadquarters
- HQ city
- Daejeon
- HQ country
- South Korea
- HQ region
- Asia
Offices7 records
Markets served
Wontech Co. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Equipment Sales: Sale of laser and energy-based medical devices including Oligio series, Picocare, Lavieen, Sandro Dual, V-Laser, and Holinwon surgical devices. One-time capital equipment sales with varying price points.
- Consumables (Tips): Recurring consumable revenue from proprietary tips and cartridges used with equipment. Q1 2026 consumables sales reached 74 billion KRW, representing stable recurring revenue stream following equipment sales.
- Home Beauty Devices: Planned entry into consumer market with Oligio Home branded home beauty devices. Strategy to expand from B2B to B2C direct customer engagement through consumer product line.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Oligio X Professional RF Device |
| Unit Pricing | Pay-as-you-go | Consumables/Tips |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Wontech Co. product offering
Product offeringCore offering
Wontech designs, manufactures, and sells laser and energy-based medical devices for aesthetic and surgical applications. Its portfolio includes monopolar/bipolar RF lifting systems (Oligio family), picosecond pigment lasers (PicoAlex, PicoAndy, PicoCare), thulium and holmium surgical lasers (Lavieen, HOLINWON series), Q-switched and dual-wavelength platforms (Sandro Dual, Pastelle PRO), and dedicated vascular and tightening systems (VeinCare, Tightan, V-Laser), sold to clinics, hospitals, and licensed medical professionals in 80+ countries.
Product overview
Wontech Co., Ltd. is a South Korean medical device company specializing in laser and energy-based technologies for medical aesthetics and surgical applications. The product portfolio includes: RF-based aesthetic devices (Oligio, Oligio X, Oligio Kiss, Tightan), picosecond lasers (PicoAlex, PicoAndy, Picocare Majesty), thulium lasers (Lavieen), hybrid laser systems (Sandro Dual), Q-switched lasers (Pastelle, Pastelle PRO), vascular lasers (V-Laser, VeinCare), and holmium surgical lasers (HOLINWON PRO, HOLINWON PRIMA). The company also offers home beauty devices and healthcare solutions including PETRA & LIME biometric monitoring and ELLISE pain treatment platform. Products serve dermatologists, plastic surgeons, MedSpa owners, and urologists across 80+ countries.
Differentiator
Problem solved
Functional benefit
Brands
- Oligio: Monopolar RF device for skin lifting and tightening; flagship product line including Oligio, Oligio X, and Oligio KISS variants.
- Lavieen
- Picocare
- Sandro Dual
- Pastelle Pro
- Tightan
- V-Laser
- HOLINWON (홀인원)
- VeinCare
- WONTECH MALL
- Wave
Products and services
- Oligio X
- Oligio
- Oligio Kiss
- Lavieen
- PicoAlex
- PicoAndy
- PicoCare
- Sandro Dual
- Pastelle PRO
- Tightan
- V-Laser
- HOLINWON PRO
- HOLINWON PRIMA
- VeinCare
- PETRA & LIME
- ELLISE
Quantifiable outcome
- 71.1% gross margin in Q1 2026, up from 64.2% year prior
- +3 more outcomes
Companies that use Wontech Co.
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Wontech Co. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature8 records
Wontech Co. partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor.
- Korean National Medical CenterminorClinical training partnership with Korean National Medical Center for Global Proctor ship Program; Dr. Kim Woo-sik leading training on VeinCare 1940 endovenous laser ablation procedures.
- Chanhee Surgery ClinicminorClinical training partnership with Dr. Park In-soo for EVLA training using Holinwon equipment as part of Global Proctor ship Program for international physicians.
- Major Korean Cosmetics ODM ManufacturersminorCollaboration with leading Korean cosmetics ODM manufacturers for medical skincare product development under Oligio Home brand.
- Sheep Medical (Japan)minorStrategic investment in Japanese medical company Sheep Medical; collaboration with Japanese hospital network for market development in Japan.
Scale indicators11 records
Recent moves14 records
Expansion highlights6 records
Wontech Co. competitors and assessment
Company assessmentDirect peers
- Cynosure (Hologic): US-based developer of light-based aesthetic systems including RF, picosecond and hair-removal platforms; competes head-to-head with Wontech's Oligio, Picocare and Sandro Dual lines globally.
- Cutera: US aesthetic device company with RF (TruBody/TruSculpt) and laser platforms; competing for the same US aesthetic-clinic capital-equipment budgets as Wontech's Oligio X.
- InMode: Israeli aesthetic device maker specializing in RF, IPL and laser platforms for body contouring and skin; competes with Wontech in the physician-office aesthetic capital-equipment segment.
- Lumenis (Boston Scientific): Pioneer in medical and aesthetic laser systems including holmium surgical lasers (urology) and aesthetic platforms — directly comparable to Wontech's Holinwon surgical and Lavieen/Pastelle aesthetic franchises.
- Lutronic: South Korean aesthetic and surgical laser/energy-based device maker with overlapping product categories (RF, picosecond, thulium, Q-switched, holmium). Most direct Korean competitor in professional aesthetics.
- Jeisys Medical: Korean competitor in energy-based aesthetic devices (HIFU, RF, lasers); overlapping product mix and same domestic channel context, recruited into Wontech's recent senior hires.
- Alma Lasers: Global leader in energy-based medical and aesthetic devices across hair removal, skin rejuvenation, body contouring, and surgical applications — closest analog at scale and competitor in aesthetic RF, laser and HIFU categories.
- BTL Industries: Leading manufacturer of non-invasive body-contouring, skin-tightening and pelvic-health energy-based devices; competes with Wontech's RF and HIFU Oligio family in aesthetic clinics and MedSpas.
Emerging players
- Sciton: US-based privately held manufacturer of laser and light-based aesthetic and surgical platforms; overlaps with Wontech in aesthetic dermatology platforms and physician-channel GTM.
Broad incumbents
- Syneron Candela: Established global aesthetics incumbent offering a broad portfolio of laser, RF and IPL systems; competing portfolio overlap with Wontech across multiple product lines.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights6 records
Customer concentration
Wontech Co. social profiles
Digital presenceWontech Co. compliance and trust
Trust signalCompliance19 records
Wontech Co. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wontech Co. leadership team
Management profileNumber of profiles
Profiles4 records
Wontech Co. subsidiaries and ownership
Company hierarchySubsidiaries4 records
Wontech Co. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wontech Co. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wontech Co.
What does Wontech Co. do?
Wontech designs, manufactures, and sells laser and energy-based medical devices for aesthetic and surgical applications. Its portfolio includes monopolar/bipolar RF lifting systems (Oligio family), picosecond pigment lasers (PicoAlex, PicoAndy, PicoCare), thulium and holmium surgical lasers (Lavieen, HOLINWON series), Q-switched and dual-wavelength platforms (Sandro Dual, Pastelle PRO), and dedicated vascular and tightening systems (VeinCare, Tightan, V-Laser), sold to clinics, hospitals, and licensed medical professionals in 80+ countries.
Is Wontech Co. a public or private company?
Wontech Co. is a public company. It is classified as public and is currently operating.
When was Wontech Co. founded?
Wontech Co. was founded in 1999. It employs 51 to 100 people.
Where is Wontech Co. based?
Wontech Co. is headquartered in Daejeon, South Korea, in the Asia region.
How does Wontech Co. make money?
Three revenue lines are on record. Equipment Sales are the primary driver. The others are consumables (Tips) and home Beauty Devices.
Who are Wontech Co.'s main competitors?
Direct peers on record are Cynosure (Hologic), Cutera, InMode, Lumenis (Boston Scientific), Lutronic, Jeisys Medical, Alma Lasers and BTL Industries. Sciton is listed as an emerging player. Syneron Candela is listed as a broad incumbent.
Does Wontech Co. have an API?
No public API is recorded for Wontech Co..
What industry is Wontech Co. in?
Wontech Co.'s product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology, with a secondary code of HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser). Its NAICS code is 334510 and its SIC code is 3841.